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Drosophilarus (WNV) infection of insect cells induces a protective RNAi response, Drosophila
melanogaster S2 and Aedes albopictus C6/36 cells were infected with WNV, and the production of WNV-
homologous small RNAs was assayed as an indicator of RNAi induction. A distinct population of ~25 nt WNV-
homologous small RNAs was detected in infected S2 cells but not C6/36 cells. RNAi knockdown of Argonaute
2 in S2 cells resulted in slightly increased susceptibility to WNV infection, suggesting that some WNV-
homologous small RNAs produced in infected S2 cells are functional small interfering RNAs. WNV was shown
to infect adult D. melanogaster, and adult ﬂies containing mutations in each of four different RNAi genes
(Argonaute 2, spindle-E, piwi, and Dicer-2) were signiﬁcantly more susceptible to WNV infection than
wildtype ﬂies. These results combined with the analysis of WNV infection of S2 and C6/36 cells support the
conclusion that WNV infection of D. melanogaster, but perhaps not Ae. albopictus, induces a protective RNAi
response.
© 2008 Elsevier Inc. All rights reserved.Introduction
Introduction of long double-stranded RNA (dsRNA) into the
cytoplasm of cells either experimentally or by viral infection results
in the suppression of gene expression via RNA interference (RNAi)(Fire
et al., 1998). The long dsRNAs are degraded by an RNAse III-type
endonuclease called Dicer into 21–28 nt small interfering RNAs
(siRNA) (Bernstein et al., 2001; Ketting et al., 2001; Knight and Bass,
2001). Single strands of the siRNAs are then incorporated into a RNA-
induced silencing complex (RISC), where they direct RISC binding to
target mRNAs containing complementary sequences (Hammond et al.,
2000). The nuclease activity of the argonaute-2 protein of RISC then
degrades the target mRNA, silencing its expression (Liu et al., 2004;
Meister et al., 2004). RNAi also includes at least two other pathways by
which dsRNAs trigger the silencing of endogenous gene expression by
translational suppression via microRNAs and transcriptional suppres-
sion via changes in chromatin structure (Meister and Tuschl, 2004;
Mello and Conte Jr, 2004).
The siRNA-mediated RNAi pathway has been shown to provide
innate immunity against viral infection in the nematode Caenorhabditis, Wadsworth Center, New York
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l rights reserved.elegans (Lu et al., 2005; Schott et al., 2005;Wilkins et al., 2005), the fruit
ﬂy Drosophila melanogaster (Galiana-Arnoux et al., 2006; van Rij et al.,
2006; Wang et al., 2006; Zambon et al., 2006), and the mosquito Ano-
pheles gambiae (Keene et al., 2004; Li et al., 2004). Mutations to
components of the RNAi pathway in each species have been shown to
increase the susceptibility of that species to infection by one or more
RNAviruses. Since the experimental introduction of long dsRNA induces
RNAi across a broad spectrumof invertebrates, it is likely that RNAi has at
least the capacity to provide natural antiviral immunity in many, if not
all, invertebrate animals (Li and Ding, 2005; Marques and Carthew,
2007). It is unclear if RNAi provides innate immunity against viral
infection inmammals. The primary response ofmammalian cells to viral
infection or experimentally introduced long dsRNAs is activation of the
interferon response (Gantier and Williams, 2007; Takeuchi and Akira,
2007).While strong inductionof the interferon responsemight preclude
induction of the RNAi pathway, even mammalian cells lacking key
components of the interferon response, fail to induce an RNAi response
when exposed to long dsRNAs, suggesting that differentiated mamma-
lian cells lack the intrinsic ability to activate the RNAi pathway in
response to long dsRNAs (Sledz et al., 2003). In contrast, some
mammalian viruses express proteins that can suppress the RNAi
pathway, at least as assayed in invertebrate cells, which has been
interpreted as evidence that mammalian viruses might normally be
subject to RNAi-mediated suppression (Li et al., 2004).
Arboviruses are a large group of RNA viruses that are transmitted
between hosts by arthropod vectors, primarily mosquitoes. Many are
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idae), Chikungunya virus (CHIKV; Togaviridae), and West Nile virus
(WNV; Flaviviridae). The sporadic emergence and spread of arboviral
diseases is a persistent public health risk in both tropical and
temperate regions of the world (Gubler, 2002; Mackenzie et al.,
2004; Solomon, 2004). For example, a new strain of CHIKV that
emerged in Africa in 2004 has created a large-scale epidemic across
South Asia, thus far causing more than a million cases of disease and
hundreds of deaths (Charrel et al., 2007; Murdur, 2007), and WNV
ﬁrst appeared in the Western Hemisphere in New York City in 1999,
and spread rapidly across North American, thus far causing more than
10,000 cases of neuroinvasive disease and 930 deaths in the United
States (Beasley, 2005; Hayes and Gubler, 2006; Hayes et al., 2005;
Kramer et al., 2007)(www.cdc.gov/ncidod/dvbid/westnile/surv&
control.htm).
The early demonstration that RNAi could be used to suppress gene
expression in the dipteran insect D. melanogaster (Caplen et al., 2000;
Kennerdell and Carthew, 1998; Misquitta and Paterson, 1999) raised
the prospect of being able to use RNAi to genetically engineer
mosquitoes to be resistant to arbovirus infection, and ultimately, use
the resistant mosquitoes as biocontrol agents to suppress disease
transmission (James, 2000). Mosquitoes clearly have a functional
siRNA-mediated RNAi pathway. RNAi has been used experimentally to
suppress gene expression in a variety of mosquito cell line lines
(Brown et al., 2003b; Hoa et al., 2003; Konet et al., 2007; Levashina
et al., 2001), as well as in adult mosquitoes inwhich dsRNAs have been
delivered via direct injection into the hemocoel and by expression
from viral vectors and germline transgenes (Attardo et al., 2003; BianFig. 1. Detection of WNV-homologous small RNAs in infected S2 cells. (A) D. melanogaster
infected withWNV at the indicatedMOI, and the cells incubated at 28 °C (S2 and C6/36) or 37
in the culture mediumwas determined by plaque assay. (B) On the days indicated (arrows in
analyzed by Northern-blot hybridization. Uninfected cells were collected as a control (lane
homologous to negative-sense WNV sequences are indicated with an arrow. The positions o
bromide-staining pattern in the region of the gel containing the 5s rRNA and tRNAs is showet al., 2005; Blandin et al., 2002; Brown et al., 2003a; Hoa et al., 2003).
RNAi has also been used to make mosquito cells resistant to DENV
infection (Adelman et al., 2002; Caplen et al., 2002), andmost recently,
resistance to DENV infection has been engineered into Aedes aegypti
by expressing DENV-homologous hairpin RNAs from germline
transgenes (Franz et al., 2006).
While it is clear from the aforementioned studies that exposing the
RNAi pathway of mosquitoes to DENV-homologous dsRNAs can confer
resistance to subsequent DENV infection, such studies do not address
the question of whether a DENV infection itself induces a protective
RNAi response that modulates infection, akin to what has been
demonstrated for viral infection in D. melanogaster and C. elegans.
What is the role, if any, for example, of the RNAi pathway in determining
the normal susceptibility of mosquitoes to infection by different
arboviruses? There is evidence that RNAi-mediated innate immunity
modulates susceptibility of An. gambiae to infection by the alphavirus
O'nyong-nyong (ONNV; Togaviridae)(Keene et al., 2004). Whether RNAi
provides a general antiviral response for other arboviruses and other
mosquito species, however, and particularly for infection of culicine
mosquitoes by ﬂaviviruses such as DENV or WNV, is not know.
To determine if WNV infection of insect cells induces an RNAi
response, we infected D. melanogaster S2 and Ae. albopictus C6/36 cells
withWNV and looked forWNV-homologous small RNAs as an indicator
of RNAi induction. Small RNAswere detected in the S2 but not the C6/36
cells. Drosophila genetics were then used to rigorously test if WNV
infection induces an RNAi response in adult D. melanogaster. Adult ﬂies
containing mutations in each of four different genes of the RNAi
pathway were shown to be signiﬁcantly more susceptible to WNVS2 cells, Ae. albopictus C6/36 cells and African green monkey kidney cells (Vero) were
°C (Vero). At various times after infection, the concentration of infectious virus particles
panel A and labels in panel B), cells were harvested, and small RNAs were isolated and
c). Day 2 for Vero cells is before widespread cytopathy is detected. 25-nt small RNAs
f 30-nt 2S ribosomal RNA and 21-nt bantam microRNA are indicated. (C) The ethidium
n as a loading control.
Table 1
Affect of AG02 knockdown on WNV infection of S2 cells
AG02 Lac Z
Hours post infection PFU/ml, each replicate PFU/ml, each replicate
18 0, 0 0, 0
24 60, 60, 10, 0 0, 0, 0, 0
36 556, 378 860, 650
48 2200, 2200, 956, 733 3300, 1200, 900, 800
S2 cells were transfected with siRNAs directed against AGO2 or Lac Z and then infected
with 5 MOI of WNV. At the indicated times after infection, the concentration of
infectious virus particles in the culture medium was determined by plaque assay.
199H.L. Chotkowski et al. / Virology 377 (2008) 197–206infection than wildtype ﬂies, supporting the conclusion that WNV
infection of D. melanogaster induces a protective RNAi response.
Results
WNV siRNAs in infected S2 cells
WNV-homologous siRNAs are predicted to be produced in infected
cells if WNV infection induces an RNAi response. We looked for the
production of such siRNAs in 3 different cell lines: African green
monkey kidney cells (Vero), Ae. albopictusmosquito cells (C6/36), and
D. melanogaster fruit ﬂy cells (S2). WNV infection would not be
expected to produce siRNAs in Vero cells, since long dsRNAs do not
induce the RNAi pathway in mammals (Caplen et al., 2000). This is
true even in cells, like Vero cells, in which dsRNA fails to induce an
interferon response, the primary pathway activated by long dsRNA in
mammals (Emeny and Morgan, 1979; Sledz et al., 2003). In contrast,
induction of the siRNA-mediated RNAi pathway is the primary
response to long dsRNA in plants and invertebrates and has been
shown to provide innate immunity against infection by RNA viruses in
these organisms (Ding et al., 2004; Li and Ding, 2005). D. melanogaster
S2 cells have been one of the primary resources used to both
characterize and use the siRNA-mediated RNAi pathway (Boutros
et al., 2004; Caplen et al., 2000), and mosquito C6/36 cells have been
shown to have a functional siRNA-mediated RNAi pathway inducible
by long dsRNA (Adelman et al., 2002; Caplen et al., 2002). C6/36 cells
are highly susceptible to WNV infection and are routinely used for
studies of WNV and other arboviruses, while D. melanogaster S2 cells
have been shown previously to be susceptible to WNV infection
(Hannoun and Echalier, 1971). S2 and C6/36 cells, therefore, provided
the opportunity to ask whether WNV infection produces WNV-
homologous small RNAs in insect cells known to have RNAi pathways
inducible by long dsRNAs.
The three cell types were infected with WNV, and the production
of WNV-homologous small RNAs was monitored by Northern-blot
hybridization. The S2, C6/36, and Vero cells were infected at MOIs of 5,
1, and 0.1, respectively, MOIs inversely related to each cell type's
sensitivity to infection. Vero and C6/36 cells produced virus titers of
~108 PFU/ml 1 and 3 days after inoculation, respectively, while
infected S2 cells required 6 days to produced titers of ~106 PFU/ml
(Fig. 1A). Total RNA was extracted from cells at various times after
infection, enriched for small RNAs, and analyzed by Northern-blot
hybridization. A discrete population of WNV-homologous small RNAs
~25 nt in length were detected in infected S2 cells but not in infected
C6/36 or Vero cells (Fig. 1B). Although larger than the 21- to 23-nt
siRNAs characteristically produced in in vitro RNAi reactions, the
WNV-homologous small RNAs, are comparable in size to repeat-
associated siRNAs produced from double-stranded RNAs originating
from endogenous or transgenic repeated genes in the D. melanogaster
genome (Aravin et al., 2003; Aravin et al., 2001; Bernstein et al., 2001;
Elbashir et al., 2001; Pal-Bhadra et al., 2002; Sarot et al., 2004; Zamore
et al., 2000). The results illustrated were obtained using a single-
stranded riboprobe that hybridizes to negative-senseWNV sequences.
Only negative-sense siRNAs are capable of directing RISC binding to
positive-sense WNV genomes, stimulating their degradation, and
thereby inhibiting infection. Also, WNV negative-sense RNAs must
originate from double-stranded viral replication intermediates where
the negative-sense strand is synthesized. Riboprobes that hybridize to
positive-sense WNV sequences also identiﬁed small RNAs in samples
of S2 RNA, as would be predicted, but such RNAs would not be
involved in RISC-associated suppression of infection, and from a
technical stand point, are more difﬁcult to deﬁnitively exclude as
arising from degradation of abundant positive-strand viral genomes
present in the cell (data not shown). The absence of small RNAs in the
C6/36 cells is unlikely to be due to technical problems, as the positive
results observed for S2 cells provided a positive control for theexperiment. The data illustrated in Fig. 1 are from a single experiment
in which RNA samples from all three cell types were processed and
analyzed in parallel, and the two Northern-blot panels illustrated are
from different sections of the same blot. The ~4-kb size of the
riboprobe, combined with the low hybridization stringencies used to
ensure stable hybridization between the probe and small RNAs,
resulted in some nonspeciﬁc hybridization to bulk RNA present on the
blots, including the 30-nt 2S ribosomal RNA in S2 cells (Fig.1B). Finally,
control riboprobes of comparable size and speciﬁc activity, but with
homology to D. melanogaster genomic sequences unrelated to WNV,
did not hybridize to any RNAs unique to infected S2 cells (data not
shown).
While the production of a discrete population of WNV-homo-
logous small RNAs in infected S2 cells is consistent with WNV
infection of these cells inducing an RNAi response, we needed to
determine whether the observed WNV-homologous small RNAs were
actually functional siRNAs capable of inhibiting infection. This was
determined by measuring virus production in infected S2 cells in
which the RNAi pathway had been suppressed by knockdown of Ar-
gonaute 2 (AGO2) expression. AGO2 encodes the primary argonaute
protein in D. melanogaster responsible for siRNA-mediated RNAi
(Hammond et al., 2001; Okamura et al., 2004), and both knockdown of
AGO2 in S2 cells and mutation of AGO2 in ﬂies has been shown to
disrupt RNAi-mediated innate immunity against infection by RNA
viruses (Li et al., 2002; Li et al., 2004; van Rij et al., 2006; Wang et al.,
2006; Zambon et al., 2006). S2 cells were transfected with synthetic
siRNAs against AGO2, or against bacterial lacZ sequences as a negative
control, and the cells infected with WNV. At various times after
infection, the titer of virus released into the culture medium was
quantitated. The speciﬁc AGO2 siRNAs used were shown previously to
suppress the RNAi pathway in S2 cells (Li et al., 2004). Virus was
detected earlier in AGO2-treated cells compared to the lacZ controls. In
3 of 4 independent replicates of AGO2-treated cells, virus was ﬁrst
detected 24 h post infection (p.i.), while in control cells, virus was not
detected in 4 of 4 replicates at 24 h p.i., but was ﬁrst detected at 36 h p.i.
(Table 1; P≤0.089 for 24 h data, t-test). No differences in viral titer
were observed between the AGO2 and lacZ-treated cells at 36 and 48 h
p.i. (Table 1; P≤0.97 for 48 h data, t-test). While admittedly a modest
effect, the earlier production of virus in AGO2-treated cells is
nonetheless consistent with at least some of the WNV-homologous
small RNAs detected in infected S2 cells being functional, RISC-
associated siRNAs capable of inhibiting WNV infection. The small
magnitude of the effect could reﬂect the intrinsic weakness of the
RNAi pathway's ability to inhibit WNV infection, or alternatively, may
be a consequence of technical limitations in the experimental system.
It is likely, for example, that the number of individual cells in the
culture that are both transfected by siRNAs and infection with virus
might be quite low if, as we suspect, the efﬁciencies of both siRNA
transfection and virus infection are low. In addition, using the RNAi
pathway to knockdown a component of the RNAi pathway is
inherently self-limiting, thus limiting the level of AGO2 knockdown
that can be achieved by this approach.
Fig. 2. The ID50 for WNV injected into D. melanogaster and Cx. pipiens. The indicated
number of PFUs of WNV was injected into adult female D. melanogaster (A) and Cx.
pipiens (B). After seven days at 27 °C, the titer of WNV in each animal was determine by
plaque assay and is indicated by a triangle. The lower limit of detection for the assays is
indicated by a dashed line. All animals for which no PFUs were detected are indicated by
a single triangle below the dashed line. The total number of animals scored as infected
and uninfected at each dose of WNV is indicated above and below the dashed line,
respectively.
Fig. 3. Kinetics of infection in D. melanogaster and Cx. pipiens. Approximately 10-times
the ID50 of infectious WNV particles were injected into adult female D. melanogaster
(ﬁlled circles) and Cx. pipiens (open circles), and the animals incubated at 27 °C for
14 days. At the times indicated, individual animals were homogenized, and the titer of
WNV was determined either by measuring the number of PFUs in each lysate by plaque
assay (A), or by measuring the number of WNV genomes in each lysate by 5′ nuclease
real-time RT-PCR (B). The mean and standard deviation from measurements made on
6–10 animals is shown for each time point. The lower limit of detection for the plaque
assay is indicated by a dashed line.
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We reasoned that classical genetic approaches available with
D. melanogaster might provide the necessary tools to rigorously
demonstrate thatWNV infection ofD.melanogaster induces a protective
RNAi response. AGO2 mutations are available in D. melanogaster,
providing the opportunity to directly compare infection susceptibility
in wildtype and AGO2 mutant ﬂies, assuming, of course, that WNV can
infect adult ﬂies. Given the broad host range of WNV and the fact that
WNV can infect S2 cells, it seemed reasonable to expect that WNV
would be able to infect adult ﬂies (Hannoun and Echalier, 1971; Lawrie
et al., 2004; Mumcuoglu et al., 2005).
Initial attempts to infect D. melanogaster by feeding them WNV
were unsuccessful, but infection could be successfully initiated by
injecting virus into the hemocoel. WNV infection of D. melanogaster
was characterized in relation to WNV infection (also by hemocoel
injection) of Culex pipiens, the primary vector of WNV in the
Northeastern U.S. (Bernard et al., 2000). First, the dose of virus at
which 50% of injected animals become infected (ID50) was determined(Fig. 2). Increasing titers of WNV were injected into adult females of
each species, the animals incubated at 27 °C, and the titer of virus
produced in individual animals was determined by plaque assay at
day 7 p.i. The ID50 for D. melanogaster was ~21 PFU compared to ~1.6
PFU for Cx. pipiens (Fig. 2; calculated using program ID50 5.0). A higher
ID50 in D. melanogaster is not surprising given that D. melanogaster is
separated from mosquitoes by ~250 million years of evolution, likely
reducing the efﬁciency of host:virus interactions the virus requires for
replication (Zdobnov et al., 2002).
We next compared the kinetics of WNV replication during the
course of infection in the two species (Fig. 3). Animals of each species
were inoculated with ~10-times their respective ID50 of WNV, and
then incubated at 27 °C for 14 days. The titer of virus in individual
animals was determined by plaque assay at various times p.i. (Fig. 3A).
In both species, infectious virus accumulated rapidly during the ﬁrst
5–6 days (acute phase), followed by slower accumulation fromdays 6–
14 (plateau phase). D. melanogaster had an initial lag in virus
production such that the ﬁrst clear evidence of viral replication was
seen at day 2 p.i. compared to day 1 for Cx. pipiens. The low levels of
virus detected in D. melanogaster 12 and 24 h p.i. most likely represent
residual inoculum as the levels are below the amounts initally
injected. The initial lag in virus production combined with a slightly
slower rate of increase between days 2–5 resulted in D. melanogaster
having ~10-fold lower virus titers at all time points tested.
The kinetics of infection was also quantitated by measuring the
accumulation of WNV genomes by 5′-nuclease real-time RT-PCR
(Fig. 3B). As observed by plaque assay, there was an initial lag in the
Fig. 4. AGO2 mutant ﬂies are more susceptible to WNV infection. 2 PFU of WNV was
injected into wildtype Oregon R (OR) and mutant AGO2414/AGO251B (AGO2) ﬂies. After
7 days at 27 °C, the titer of WNV in each ﬂy was determined by plaque assay and is
indicated by a triangle. The lower and upper limits of detection for the assay are
indicated by dashed lines. All ﬂies for which no PFUs were detected are indicated by a
single triangle below the lower limit of detection, with the total number of uninfected
ﬂies indicated below this triangle. The total number of ﬂies scored as infected is
indicated above the upper dashed line. The average titer for all infected ﬂies for each
genotype is indicated by a horizontal line.
Fig. 5. AGO2mutant ﬂies have higher titers of WNV. Approximately 10-times the ID50 of
infectious WNV particles were injected into wildtype and AGO2414/AGO251 mutant ﬂies,
and the ﬂies cultured at 27 °C. At the times indicated, individual ﬂies were
homogenized, and the titer of WNV was determined by 5′ nuclease real-time RT-PCR.
Themean and standard error frommeasurementsmade on 10–11 ﬂies is shown for each
time point.
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with the ﬁrst evidence of viral replication in D. melanogaster being
seen at day 2 p.i. compared to as early as 12 h for Cx. pipiens. In
D. melanogaster, genomes accumulated rapidly from days 2–5 p.i. and
then continued to increase slowly through day 14. In Cx. pipiens, WNV
genomes accumulated rapidly to day 3 p.i., then remained essentially
constant through day 14. The longer period of proliferation and
continued increase in genome copy number through day 14 p.i.
resulted in D. melanogaster accumulating more WNV genomes per
animal than Cx. pipiens after about day 5 p.i. The total amount of RNA
extracted from individual animals was roughly equivalent for the two
species, so the same relative similarities and differences were
observed whether genome copy number was quantitated per animal
or standardized to the amount of RNA in each extract (data not
shown). The greater number of viral genomes, yet lower number of
infectious particles, measured in D. melanogaster compared to Cx.
pipiensmay suggest that some aspect of particle assembly may be rate
limiting during WNV infection of ﬂies. Alternatively, the number of
WNV particles produced in ﬂies could actually be higher than is
suggested by Vero cell plaque assays if WNV particles produced in ﬂies
are intrinsically less efﬁcient at infecting Vero cells than particles
produced in mosquitoes. Finally, WNV infection of D. melanogaster
caused no obvious detrimental effects on the viability, motility,
fertility, fecundity, or CO2 sensitivity of infected ﬂies up to day 30 p.i.
(data not shown).
AGO2 mutations increase susceptibility to WNV infection
Having established that WNV can infect adult ﬂies, we then
measured the susceptibility of AGO2 mutant ﬂies to WNV infection.
Approximately 2 PFU of WNV was injected into wildtype and AGO2
mutant ﬂies, and at day 7 p.i., the titer of virus in each ﬂy was
measured by plaque assay (Fig. 4). Flies were infected with a limiting
inoculum of virus (2 PFU) in order to maximize the sensitivity of the
assay at revealing increased susceptibility in the AGO2 mutants.
AGO2414/AGO251B compound-heterozygous ﬂies containing two differ-
ent AGO2 mutant chromosomes were tested to avoid potentiallyconfounding phenotypes that can arise from homozygosing recessive
background mutations. AGO2 mutant ﬂies were signiﬁcantly more
susceptible to infection thanwildtype ﬂies (Fig. 4). Only 3 of 74wildtype
ﬂies (4%) had detectable virus compared to 32 of 86 AGO2 mutants
(37%), a 9-fold increase in frequency. In addition, the titer of virus in
infected ﬂies was at least 17-fold higher in AGO2mutants compared to
wildtype (P≤0.0041, t-test).
We also characterized the kinetics of infection in AGO2 mutant
ﬂies, predicting that AGO2 mutants would accumulate virus at a
higher rate during infection than wildtype ﬂies. Approximately 10-
times the ID50 of WNV was injected into wildtype and AGO2 mutant
ﬂies, and at various times after inoculation, the titer of WNV genomes
was measured by 5′-nuclease, real-time RT-PCR. The number of
genomes measured at days 3, 5, and 7 p.i. were all signiﬁcantly higher
in AGO2 mutants compared to wildtype (P≤0.035, P≤0.0012,
P≤0.0015, respectively; t-test), ultimately producing ~4-fold higher
titer of genome copy number at days 5 and 7 p.i. (Fig. 5). So, even at
high inoculums of virus, AGO2 mutants accumulated signiﬁcantly
moreWNV genomes during the course of infection thanwildtype ﬂies.
We conclude from this result, as well as the increased frequency of
infection shown in Fig. 4, that mutation to AGO2 increases the
susceptibility of ﬂies to WNV infection.
Mutation of other RNAi genes also increases susceptibility
AGO2 encodes functions in D. melanogaster beyond its role in
siRNA-mediated RNAi. AGO2 has overlapping functions with AGO1 in
translational repression via the microRNA pathway and with the RITS
pathway that regulates formation of centromeric heterochromatin
(Deshpande et al., 2005; Meyer et al., 2006). In addition, AGO2 plays a
role in siRNA-independent turnover of speciﬁc transcripts (Xu et al.,
2004). These alternate functions raise the possibility that the
increased susceptibility to WNV infection seen in AGO2 mutations
could be a consequence, directly or indirectly, of disruption to non-
siRNA-mediated pathways. To address this possibility, we tested
whether mutation to other RNAi genes known to contribute to innate
immunity against RNA viruses would, like mutation to AGO2, increase
susceptibility to WNV infection. We reasoned that if WNV infection
induces a protective RNAi response, then mutation to other RNAi
genes involved in this response should also increase susceptibility.
Furthermore, if mutations in multiple RNAi genes increase suscept-
ibility, then gene-speciﬁc effects on siRNA-independent pathways are
less likely to be the origin of the observed increase in susceptibility.
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three genes: spindle-E (spn-E; also called homeless [hls]), piwi, and
Dicer-2 (Dcr-2). spn-E encodes a DExH-class RNA helicase, which are
involved in assembly of both RISC and RITS complexes, and has been
shown to inﬂuence susceptibility of ﬂies to Drosophila X virus (DXV;
Birnaviridae) (Aravin et al., 2001; Gillespie and Berg, 1995; Kennerdell
et al., 2002; Pal-Bhadra et al., 2004; Stapleton et al., 2001; Zambon
et al., 2006). The primary function of piwi, the founding member of
the argonaute gene family, is in maintaining genome integrity in the
germline, but it has also been shown to have somatic functions,
including inﬂuencing the susceptibility of ﬂies to DXV infection
(Aravin et al., 2006; Cox et al., 1998; Girard et al., 2006; Klattenhoff
and Theurkauf, 2008; Pal-Bhadra et al., 2002; Pal-Bhadra et al., 2004;
Saito et al., 2006; Zambon et al., 2006). Dcr-2 encodes the RNAse III
enzyme in D. melanogaster primarily responsible for production of
siRNAs (Lee et al., 2004). Dcr-2 has been shown to play a role in the
RNAi-mediated antiviral response against infection of D. melanogaster
by a number of viruses including Flock House virus (FHV; Nodaviri-
dae), Cricket Paralysis virus (CrPV; Dicistroviridae), Drosophila C virus
(DCV; Dicistroviridae), and Sindbis virus (SINV; Togaviridiae) (Galiana-
Arnoux et al., 2006; van Rij et al., 2006; Wang et al., 2006).Fig. 6. Mutation to other RNAi genes also increases titers of WNV. Approximately 10-
times the ID50 of infectious WNV particles was injected into wildtype, spn-EhlsΔ125/spn-
EhlsE616, piwi1/piwi2, and Dcr-2R416X/Dcr-2L811fsX mutant ﬂies, and the ﬂies cultured at
27 °C. spn-E and piwi mutants were analyzed in one experiment (A), and Dcr-2 in
another (B). At the times indicated, individual ﬂies were homogenized, and the titer of
WNV was determined by 5′ nuclease real-time RT-PCR. The mean and standard
deviation from measurements made on 9–20 individual ﬂies is shown for each time
point.The kinetics of infection in spn-E, piwi, and Dcr-2 mutants was
characterized relative to wildtype ﬂies. Compound-heterozygous ﬂies
were created for each gene to avoid potentially confounding
phenotypes arising from homozygosing recessive background muta-
tions, as was done for AGO2. Approximately 10-times the ID50 of WNV
was injected into mutant and wildtype ﬂies, and at various times after
inoculation, the titer of WNV genomes was measured by 5′-nuclease,
real-time RT-PCR (Fig. 6). Mutations in spn-E and piwi both produced
increased rates of WNV replication from days ~2–5 p.i., resulting in
signiﬁcantly higher titers ofWNVgenomes (Fig. 6A). Higher titerswere
seen at days 5 and 7 in spn-E mutants (P≤0.00012 and P≤2.7×10−14,
respectively; t-test) and at days 3, 5, and 7 for piwi mutants
(P≤0.00013, P≤6.8×10−6, and P≤7.1×10−14, respectively; t-test). The
increased rates of WNV replication ultimately produced ~10-fold
higher titers of WNV genomes at day 7 p.i. in both mutants (Fig. 6A).
Mutation of Dcr-2 did not produce increased rates of WNV replication
from days 1–5 p.i. and actually had lower titers of virus at those time
points (Fig. 6B). The rate of WNV replication, however, did continue to
increase from days 5–7 p.i. when replication in wildtype ﬂies was
essentialﬂat, producing ~2-fold higher titers ofWNVgenomes at day 7
p.i. (P≤0.042, t-test; Fig. 6B). The modest effect of the Dcr-2mutations
was not entirely unexpected. It is known that Dcr-1, which is essential
for synthesis of microRNAs, can also synthesize siRNAs in Dcr-2
mutants (Lee et al., 2004). In addition, the effect of Dcr-2mutations on
infection susceptibility varies signiﬁcantly for different viruses. For
example,mutation ofDcr-2 increases virus titersmore than 100-fold in
DCV infected ﬂies, while having little or no effect in ﬂies infected by
DXV (van Rij et al., 2006; Zambon et al., 2006).
The increased titers of WNV seen in the piwi and spn-E mutant
ﬂies, and to a lesser extent the Dcr-2 mutants, corroborates the
increase in susceptibility seen in AGO2 mutants, consistent with
mutations in all four RNAi genes increasing the susceptibility of ﬂies to
WNV infection by disrupting the siRNA-mediated RNAi pathway.
These genetic results (Figs. 4–6), combined with the evidence that
WNV infection of D. melanogaster S2 cells produces functional WNV-
homologous siRNAs (Fig. 1 and Table 1), support the conclusion that
WNV infection of D. melanogaster induces an RNAi response that
inhibits infection.
Discussion
We infected D. melanogaster S2 and Ae. albopictus C6/36 cells with
WNV and looked for the production of WNV-homologous small RNAs
as an indicator of RNAi induction, to determine if WNV infection of
insect cells induces an siRNA-mediated RNAi response. Small RNAs
were detected in S2 but not in C6/36 cells, suggesting that an RNAi
response is induced in cells of D. melanogaster but not Ae. albopictus
(Fig. 1). RNAi knockdown of AGO2 expression resulted in S2 cells
becoming more susceptible to WNV infection, suggesting that at least
some of the small RNAs that are produced in S2 cells are functional
siRNAs (Table 1). In order to more rigorously test whether WNV
infection of D. melanogaster does, in fact, induce a protective RNAi
response, adult ﬂies containing mutations in each of four different
genes of the RNAi pathway: AGO2, spn-E, piwi, and Dcr-2, were shown
to be signiﬁcantly more susceptible to WNV infection than wildtype
ﬂies (Figs. 4–6). We conclude from these results that WNV infection of
D. melanogaster induces an siRNA-mediated RNAi response that
inhibits infection.
Signiﬁcant increases in infection susceptibility were seen in each of
four different RNAi-mutant ﬂies, suggesting that the RNAi pathway, in
toto, could be a principle reason D. melanogaster is less susceptible to
WNV infection than Cx. pipiens. Simultaneously mutating all compo-
nents of the RNAi pathway to test this idea, however, is impossible,
since some RNAi genes provide essential functions, precluding the
creation of viable ﬂies containing mutations in such genes (Lee et al.,
2004).
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cells, suggesting that WNV infection of Ae. albopictus cells does not
induce an RNAi response or induces such a minimal response that
detectable levels of siRNAs are not produced (Fig. 1). siRNAs were
detected in S2 cells even though they produced titers of WNV that
were 3 logs lower than titers produced by C6/36 cells (Fig. 1), further
suggesting that any RNAi response induced in C6/36 cells is extremely
low relative to levels of viral replication. Therefore, it is unlikely that
the siRNA-mediated RNAi pathway inhibits the susceptibility of C6/36
cells to infection by WNV. Why doesn't WNV infection of C6/36 cells
induce an RNAi response, given that WNV replication produces long
dsRNA replication intermediates in cells, and experimental introduc-
tion of dsRNAs into C6/36 cells clearly induces an RNAi response
(Adelman et al., 2002; Caplen et al., 2002; Chu and Westaway, 1985)?
Both cytological and biochemical evidence indicates that WNV
replication occurs in the context of membrane associated complexes
(Mackenzie et al., 1999; Uchil and Satchidanandam, 2003; Westaway
et al., 1997). The structure of such complexes may hide dsRNA
replication intermediates from Dicer nucleases, thus allowing the
virus to evade detection by the RNAi pathway. Alternatively, WNV
could express an inhibitor of the RNAi pathway, as has been
demonstrated for other viruses, although experiments designed to
test this possibility failed to ﬁnd any evidence for general suppression
of the RNAi pathway in WNV-infected cells, again suggesting that
evasion, rather than suppression, is the primary mechanism by which
WNV, and likely other ﬂaviviruses, avoids RNAi-mediated innate
immunity in insects (Geiss et al., 2005; Li and Ding, 2005).
The absence of an RNAi response in WNV-infected C6/36 cells, if
extrapolated to adult mosquitoes, suggests that RNAi may not play a
signiﬁcant role in determining the susceptibility of Ae. albopictus to
WNV infection. In fact, to date, there is no evidence that RNAi
normally modulates susceptibility of any mosquito species to
ﬂavivirus infection. Clearly, the RNAi pathway can be experimentally
activated to confer resistance to ﬂavivirus infection. Resistance to
DENV infection can be engineered into transgenic Ae. aegypti by
artiﬁcially activating the RNAi pathway (Franz et al., 2006). Such
experiments, however, only demonstrate that ﬂavivirus infections
can be inhibited by the RNAi pathway when RISC complexes have
been “preloaded” with virus-homologous siRNAs prior to infection,
not that ﬂaviviral infections themselves induce an RNAi response
that modulates susceptibility. In contrast, there is evidence that the
RNAi pathway may normally modulate susceptibility of An. gambiae
to infection by O'nyong-nyong virus (ONNV; Togaviridae; Alpha-
virus). RNAi-mediated knockdown of AGO2 expression increased the
susceptibility of An. gambiae to infection by ONNV (Keene et al.,
2004). It is unclear, however, the extent to which this observation
can be extrapolated to ﬂavivirus infections of culicine mosquitoes,
given differences in the mechanism of replication between alpha-
viruses and ﬂaviviruses. For example, RNA recombination has been
observed in alphaviruses but is rare or absent in ﬂaviviruses,
consistent with alphavirus replication intermediates being more
accessible than their ﬂavivirus counterparts, at least between
replication complexes and perhaps within the cytoplasm generally
(Strauss and Strauss, 1997; Twiddy and Holmes, 2003). Thus,
alphavirus dsRNA replication intermediates may be more readily
accessible to surveillance by Dicer nucleases. Elucidating the role, if
any, played by siRNA-mediated RNAi in determining the suscept-
ibility of mosquitoes to ﬂavivirus infection will require experiments
directed speciﬁcally to this question and done in relevant host:
ﬂavivirus systems.
Why does WNV infection of D. melanogaster induce a protective
RNAi response, while infection of Ae. albopictus C6/36 cells likely does
not?WNV has probably evolved to evade the RNAi pathway in natural
mosquito hosts by hiding its dsRNA replication intermediates within
membrane-associated complexes, as discussed above. In a hetero-
logous host like D. melanogaster, however, that evasion mechanismmay be compromised. For example, host:virus interactions required
for assembly of viral replication complex are likely to be suboptimal in
a heterologous host due to genetic divergence of relevant host genes.
dsRNA replication intermediates within such replication complexes
may therefore be less well protected from Dicer surveillance, allowing
activation of an RNAi response. If the genetic divergence of
D. melanogaster and the resulting reduction in the ﬁdelity of viral
replication is, in fact, the underlying reason WNV infection of
D. melanogaster induces a protective RNAi response, it would be
interesting to determine if the same is true in different species of
mosquitoes. The probability of WNV infection inducing a protective
RNAi response may be a function of how genetically divergent a
speciﬁc mosquito species is relative to mosquito species to which the
virus is optimally adapted. In this way, the RNAi pathway might limit
the host range of arboviruses, while having little or no impact on
infection susceptibility in host species to which the virus is best
adapted. Finally, it is also possible that the RNAi pathway in
D. melanogaster is quantitatively or qualitatively different in a way
that makes RNAi in ﬂies intrinsically better at inhibiting WNV
infection. Experimentally induced RNAi knockdown of endogenous
genes in C6/36 cells has been reported to beweaker than the degree of
knockdown that can be a achieved in S2 cells, consistent with this
possibility (Caplen et al., 2002).
What ultimately inhibits WNV replication at the transition from
the acute to the plateau phase of infection, is not known. The
transition occurs at a discrete time, day 3 p.i. in Cx. pipiens and day 5 in
D. melanogaster, as measured by WNV genomes (Fig. 3B). Under-
standing how WNV replication is inhibited to create this transition
might provide insights into host:virus interactions that determine the
overall kinetics of infection. Infection of AGO2, piwi, and spn-E
mutants of D. melanogaster clearly produced higher maximum titers
of WNV than infection of wildtype ﬂies, suggesting that transition to
the plateau phase of infection is not caused by viral replication
depleting a limited host resource. If that were the case, infection in
both mutant and wildtype ﬂies would be expected to produce the
same maximum virus titers, with the transition to the plateau phase
occurring earlier in mutants than in wildtype ﬂies. The transition,
however, occurred at the same time in mutant and wildtype ﬂies
(Figs. 5 and 6). Analysis of the RNAi mutants also suggests that the
RNAi response itself is probably not what ultimately limits infection. If
it were, mutations that weaken the ability of the RNAi response to
inhibit infection, like mutations in RNAi genes, would be predicted to
lengthen the time required for the RNAi response to “catch up with”
and eventually inhibit the acute phase of infection, but again, the
transition to the plateau phase of infection occurred at the same time
inmutant andwildtype ﬂies, arguing against this idea (Figs. 5 and 6). If
WNV infection is not inhibited by depletion of limited host resources
or by the RNAi pathway, then perhaps another innate immune
response activated by WNV infection plays a role. Looking at WNV
infection in ﬂies containing mutations in genes involved in other
innate immune pathways would address this possibility.
WNV's ability to infect awide phylogenetic range of hosts, including
diverse species of mammals, birds, and insects, suggests that host
genetic factors that the virus needs in order to replicate are likely to be
broadly conserved across species. WNV can infect adult D. melanoga-
ster, producing viremias similar to those in the mosquito Cx. pipiens,
and Drosophila genetics can be used to identify speciﬁc host genes that
are important forWNV infection of ﬂies (Figs. 2–6). Beyond the limited
number of RNAi genes analyzed here, unbiased, functional genetic
screens that can be done with relative ease in D. melanogaster could be
used to systematically identify host genes important forWNV infection
of ﬂies. The mosquito orthologs of genes identiﬁed in D. melanogaster
could then be tested for their importance for WNV infection of
mosquitoes, providing a systematic way to identify mosquito genes
that are important for host:virus interactions that determine infection
susceptibility.
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Cells and virus
D. melanogaster S2 cells were grown semi-adherently in 6-well plates
at 28 °C in serum free medium supplemented with 2 mM L-glutamine
(Invitrogen). Aedes albopictus cells (C6/36, ATCC #CRL-1660) and African
green monkey kidney cells (Vero, ATCC #CCL-81) were grown in 6-well
plates at 28 °C and 37 °C, respectively, in minimal essential medium
supplemented with 10% FBS, 2 mM L-glutamine, 1.5 g/l sodium
bicarbonate, 0.1 mM non-essential amino acids, 100 U/ml penicillin
and streptomycin. Cells were infected withWNV by decanting medium
from the well and adding 100 μl of virus at the appropriate multiplicity
of infection (MOI). Following a 1-h adsorption period, cells were rinsed
once, and 3 ml of fresh medium was added, and the cells incubated at
the appropriate temperature. For viral growth analysis, samples of
culture supernatant were removed at appropriate times after infection
and stored at −80 °C. The stock virus used for infections (WNV 3356)
was derived fromWNVNY003356, a primary isolate from kidney tissue
of an American crow collected in 2000 in Staten Island, NY (Ebel et al.,
2001). The virus stock was prepared by three rounds of plaque
puriﬁcation in Vero cells.
Plaque assays
Plaque assays using Vero cells were done essentially as described
previously (Payne et al., 2006). Plaque assays were done on either
culture supernatants from infected cells or homogenates of infected
ﬂies or mosquitoes. Infected animals were homogenized bymixer mill
in 500 μl of Dulbecco's phosphate-buffered saline supplemented with
20% FBS, 50 μg/ml penicillin and streptomycin, 50 μg/ml gentamicin,
2.5 μg/ml Fungizone, and stored at −80 °C until assayed.
RNAi treatment of S2 cells
S2 cells were treated with AGO2-homologous or lacZ-homologous
siRNAs once a day for 3 consecutive days, after which cells were
infected with WNV at an MOI of 5. Samples of culture supernatant
were collected at various times after infection and stored at −80 °C
until WNV titers were measured by plaque assay. On the ﬁrst day of
siRNA treatment, 1×106 cells were plated in the well of a 6-well plate
in 860 μl of medium for each sample. 140 μl of siRNA transfection mix
containing TransMessenger Transfection Reagent (Qiagen) and 7 μMof
double-stranded siRNAs was added to the cells, and the cells
incubated overnight. On days 2 and 3, the culture medium was
removed, replaced with 860 μl of fresh medium, and the cells again
treated with siRNAs as done on day 1. The siRNAs used were double-
stranded 21-mers (Qiagen). For AGO2, equal molar amounts of two
different siRNAs shown previously to inhibit the RNAi pathway in S2
cells were used (Li et al., 2004). lacZ siRNAs were used for the negative
control (Li et al., 2004).
Northern-blot analysis
Total RNA was isolated from infected cells using TRI Reagent
following the manufacturer's protocols (Molecular Research Center).
RNA samples were enriched for small RNAs by size-selective
precipitation using polyethylene glycol. Samples containing ~20 μg
of size-selected RNA were fractionated on 15% polyacrylamide-8M
urea gels and transferred to GeneScreen Plus membrane (New
England Biolabs). Blots were probed simultaneously with two
different P32-labelled riboprobes homologous to NS1 sense-strand
sequences. The primer pairs used to make the riboprobe templates
were GGATTGACGCCAGGGTGTACT and GCACTTGACGAGGACTCTCC
(1700 nt RNA), and GGCAGTTCTGGGTGAAGTCAA and GGTGAGCCT-
GATGTTCCA (1900 nt RNA). D. melanogaster bantam microRNA wasdetected on the Northern blots as a 21-nt size marker in the lanes
containing RNA from S2 cells (Brennecke et al., 2003).
Fly and mosquito strains and genetics
D. melanogaster were maintained on cornmeal-brewer's yeast-
glucose medium at 23 °C and 55% relative humidify. Wildtype
D. melanogaster were Oregon R. AGO2414/AGO251B compound hetero-
zygotes were created by crossing AGO2414 and AGO251B homozygous ﬂies
(Okamura et al., 2004; Xu et al., 2004). Dcr-2R416X/Dcr-2L811fsX compound
heterozygotes were created by crossing Dcr-2R416X and Dcr-2L811fsX
homozygous ﬂies (Lee et al., 2004). piwi1/piwi2 compound heterozygotes
were created by crossing piwi1/CyO and piwi2/CyO ﬂies (Lin and
Spradling, 1997). spn-EhlsΔ125/spn-EhlsE616 compound heterozygotes were
created by crossing spn-EhlsΔ125/TM3 and spn-EhlsE616/TM3 ﬂies (Gillespie
and Berg, 1995). Cx. pipiens mosquitoes were collected from the wild in
Pennsylvania, and had been colonized in the lab for ~6 months at the
time of their use in the experiments described. The mosquitoes were
maintained at 27 °C and 85% relative humidity with a photoperiod of
16:8 h (light:dark). Adult females were maintained in 0.5 l cardboard
cups and fed 10% sucrose ad libitum. Flies and mosquitoes were
transferred to the BSL3 insectary for virus inoculation 3–7 days or ~7
days after emergence, respectively.
Injections
D. melanogaster were anesthetized with triethylamine or ice and
injected intra-abdominally with ~100 nl of Dulbecco's modiﬁed eagle
medium (DMEM) containing WNV at the appropriate concentration.
Pre-pulled 30 μm needles were used (World Precision Instruments),
and the injection volume was controlled using a pneumatic injector.
Appropriate backpressure was determined empirically for each session
of injection. Mutant and wildtype ﬂies for any single experiment were
always injected during the same injection session using the same
injector settings and reagents, and the injected ﬂies were always
incubated together. Cx. pipiens were anesthetized with CO2 and
injected intra-thoracically with ~100 nl of DMEM containing WNV at
the appropriate concentration, essentially as described previously
(Rosen and Gubler, 1974). After injection, both species were incubated
at 27 °C with a 16:8 light/dark photoperiod.
5′ nuclease real-time RT-PCR
Total RNA was isolated using TRI Reagent following the manufac-
turer's protocol (Molecular Research Center). RNA recovery was
quantitated using Quant-iT RNA assays (Invitrogen). The amount of
WNV RNA in a 10-μl sample of each extract was determined using a 5′
nuclease real-time RT-PCR assay with a primer-probe set homologous
to sequences in the WNV envelope gene as described previously (Shi
et al., 2001). The absolute number of WNV genomes was calculated
from concurrently assayed WNV RNA standards.
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